Clinical Trials Directory

Trials / Terminated

TerminatedNCT01021176

Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell

A Single Dose Pilot Study to Evaluate the Safety and Dose-Response of Smell to Intranasal Diltiazem

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether the blood pressure medication, diltiazem, will temporarily decrease the sense of smell when given in a nasal spray which will then reduce food intake.

Detailed description

You will fast on your first visit. Complete questionnaire about taste and smell to insure you don't have a cold or anything that would interfere with sense of smell. Your nose will be checked. Blood pressure taken, and administer to you a spray with diltiazem 2, 4, 8 mg or a placebo. Your sense of smell will be tested at different time points.

Conditions

Interventions

TypeNameDescription
OTHERPlacebo spray0, 30, 60, 90, 120, 180, and 240 minutes following the nasal spray yet no drug will be administered
DRUGDiltiazem0, 30, 60, 90, 120, 180, and 240 minutes following the nasal spray Three Dilutions would be 5.5, 6.0 and 6.3 and the fourth at the filp of a coin randomly diluted.

Timeline

Start date
2009-10-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2009-11-26
Last updated
2015-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01021176. Inclusion in this directory is not an endorsement.